Ownership history in Opaleye Management Inc. Β· 11 quarters on record
This page tracks every 13F SEC filing in which Opaleye Management Inc. reported a position in GOSSAMER BIO INC (GOSS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Opaleye Management Inc. outperformed the S&P 500 by +41.1% annually on this GOSS position. Timing score: 50% (5/10 decisions correct). Average cost basis: $1.03. Maximum drawdown during holding period: β30.8%.
π₯ Exceptional β beat the S&P 500 by 41.1% per year on this position.
10 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
5 of 10 add/trim decisions correct
Best entry: $0.83 (2023 Q3) Β· Worst: $1.20 (2023 Q2)
πͺ Held through 2 major drawdowns (>20%).
4 adds Β· 7 trims. Bought during 3 of 3 down-price quarters. π Predominantly trimming β distribution phase.
π Opaleye Management Inc. has been actively increasing its GOSS allocation β a bullish signal from insiders.
Currently 1.11% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size